{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:58Z","timestamp":1761895558746,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.4158\/ep12166.ra","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T06:29:38Z","timestamp":1347690578000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"18","author":[{"given":"John P.","family":"Bilezikian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP12166.RA_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2010.03.077","article-title":"Vitamin D and primary hyperparathyroidism (PHPT)","volume":"121","author":"Souberbielle","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.4158\/EP12166.RA_bb0015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.surg.2011.09.011","article-title":"The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?","volume":"150","author":"Wallace","year":"2011","journal-title":"Surgery"},{"key":"10.4158\/EP12166.RA_bb0020","series-title":"Principles of Bone Biology.","first-page":"1327","article-title":"Familial benign hypocalciuric hypercalcemia and neonatal primary hyperparathyroidism.","author":"Fuleihan","year":"2008"},{"key":"10.4158\/EP12166.RA_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ncpendmet0388","article-title":"Clinical lessons from the calcium-sensing receptor","volume":"3","author":"Brown","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0030","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12166.RA_bb0035","series-title":"The Parathyroids.","first-page":"331","article-title":"Molecular basis of primary hyperparathyroidism.","author":"Arnold","year":"2001"},{"key":"10.4158\/EP12166.RA_bb0040","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"Incipient\" primary hyperparathyroidism: a \"forme fruste\" of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0045","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0050","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/EP12166.RA_bb0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0065","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0070","unstructured":"Cusano NE, Maalouf NM, Dworakowski E, Zhang C, Cremers SC, Bilezikian JP. Epidemiology and natural history of normocalcemic primary hyperparathyroidism and normocalcemic hypoparathyroidism. J Bone Miner Res. In press."},{"key":"10.4158\/EP12166.RA_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12166.RA_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/03009739909178956","article-title":"Primary hyperparathyroidism of postmenopausal females. Prospective case-control analysis on prevalence, clinical characteristics and treatment","volume":"104","author":"Lundgren","year":"1999","journal-title":"Ups J Med Sci"},{"key":"10.4158\/EP12166.RA_bb0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12166.RA_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1990.03450050039024","article-title":"A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood","volume":"264","author":"Cohen","year":"1990","journal-title":"JAMA"},{"key":"10.4158\/EP12166.RA_bb0095","doi-asserted-by":"crossref","unstructured":"Thakker RV, Newey PJ, Walls GV, et al. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). J Clin Endocrinol Metab. 2012 [Epub ahead of print].","DOI":"10.1210\/jc.2012-1230"},{"key":"10.4158\/EP12166.RA_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP12166.RA_bb0105","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbmr.1540","article-title":"Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography","volume":"27","author":"Hansen","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP12166.RA_bb0110","series-title":"Osteoporosis - Pathophysiology and Clinical Management.","first-page":"511","article-title":"Clinical use of parathyroid hormone in osteoporosis","author":"Bilezikian","year":"2010"},{"key":"10.4158\/EP12166.RA_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-061709-145401","article-title":"New approaches to the treatment of osteoporosis","volume":"62","author":"Silva","year":"2011","journal-title":"Ann Rev Med"},{"key":"10.4158\/EP12166.RA_bb0120","first-page":"4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0125","first-page":"1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"key":"10.4158\/EP12166.RA_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-83-3-365","article-title":"Back pain and vertebral crush fractures: an unrecognized mode of presentation for primary hyperparathyroidism","volume":"83","author":"Dauphine","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12166.RA_bb0140","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Min Res"},{"key":"10.4158\/EP12166.RA_bb0145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","article-title":"Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures","volume":"109","author":"Wilson","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12166.RA_bb0150","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.1992.00400230081014","article-title":"Risk of age-related fractures in patients with primary hyperparathyroidism","volume":"152","author":"Melton","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP12166.RA_bb0155","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometic vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-007-0793-5","article-title":"Bone quality: the material and structural basis of bone strength","volume":"26","author":"Seeman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP12166.RA_bb0165","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1359\/jbmr.2002.17.10.1741","article-title":"Parathyroid hormone and periosteal bone expansion","volume":"17","author":"Parfitt","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP12166.RA_bb0170","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1007\/s00198-003-1482-4","article-title":"Bone strength in primary hyperparathyroidism","volume":"14","author":"Bilezikian","year":"2003","journal-title":"Osteoporosis Int"},{"key":"10.4158\/EP12166.RA_bb0175","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12166.RA_bb0180","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid wurgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00774-007-0754-z","article-title":"Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study","volume":"25","author":"Tamura","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"10.4158\/EP12166.RA_bb0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/bjs.7044","article-title":"Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women","volume":"97","author":"Sitges-Serra","year":"2010","journal-title":"Br J Surg"},{"key":"10.4158\/EP12166.RA_bb0195","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.0954-6820.2003.01237.x","article-title":"Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study","volume":"255","author":"Vestergaard","year":"2004","journal-title":"J Intern Med"},{"key":"10.4158\/EP12166.RA_bb0205","series-title":"Endocrinology.","first-page":"1176","article-title":"Primary hyperparathyroidism","author":"Silverberg","year":"2010"},{"key":"10.4158\/EP12166.RA_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Suppl 3","key":"10.4158\/EP12166.RA_bb0215","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12166.RA_bb0220","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KIDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"10.4158\/EP12166.RA_bb0225","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2011-3072","article-title":"Effect of renal function on skeletal health in primary hyperparathyroidism","volume":"97","author":"Walker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","article-title":"Neuromuscular disease in primary hyperparathyroidism","volume":"80","author":"Patten","year":"1974","journal-title":"Ann Inter Med"},{"key":"10.4158\/EP12166.RA_bb0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","article-title":"Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism","volume":"87","author":"Turken","year":"1989","journal-title":"Am J Med"},{"key":"10.4158\/EP12166.RA_bb0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(94)90128-7","article-title":"Psychologic symptoms before and after parathyroid surgery","volume":"96","author":"Solomon","year":"1994","journal-title":"Am J Med"},{"key":"10.4158\/EP12166.RA_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0b013e32801173fb","article-title":"Psychiatric and cognitive aspects of primary hyperparathyroidism","volume":"19","author":"Roman","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.4158\/EP12166.RA_bb0250","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg"},{"key":"10.4158\/EP12166.RA_bb0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0039-6060(03)00316-7","article-title":"Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy","volume":"134","author":"Quiros","year":"2003","journal-title":"Surgery"},{"key":"10.4158\/EP12166.RA_bb0260","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery vs no surgery in patients with mild PHPT","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0265","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0270","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0275","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0280","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2007-0551","article-title":"Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves \"bones\" but not psychic moans","volume":"92","author":"Walker","year":"2007","journal-title":"J Clin Endocrnol Metab"},{"key":"10.4158\/EP12166.RA_bb0285","first-page":"158","article-title":"Primary hyperparathyroidism in women: a tale of two cities-New York and Beijing","volume":"45","author":"Bilezikian","year":"2000","journal-title":"Int J Fertil Womens Med"},{"key":"10.4158\/EP12166.RA_bb0290","series-title":"The Parathyroids.","first-page":"375","article-title":"Primary hyperparathyroidism in India, Brazil and China.","author":"Mithal","year":"2001"},{"key":"10.4158\/EP12166.RA_bb0295","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in human vitamin D deficiency in primary hyperparathyroidism","volume":"54","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"key":"10.4158\/EP12166.RA_bb0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"Am J Med"},{"key":"10.4158\/EP12166.RA_bb0305","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D deficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0310","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"},{"key":"10.4158\/EP12166.RA_bb0315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01726908","article-title":"Reversible hypertension in primary hyperparathyroidism-pre- and posteroperative blood pressure in 75 cases","volume":"62","author":"Ringe","year":"1984","journal-title":"Klin Wochenschr"},{"key":"10.4158\/EP12166.RA_bb0320","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-10-0201","article-title":"Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy","volume":"163","author":"Farahnak","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP12166.RA_bb0325","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0330","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0335","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/jc.2008-1757","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism revisited","volume":"94","author":"Khan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0345","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/qjmed\/hcq261","article-title":"The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study","volume":"104","author":"Yu","year":"2011","journal-title":"QJM"},{"key":"10.4158\/EP12166.RA_bb0350","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2008-1761","article-title":"Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Udelsman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","article-title":"The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism","volume":"253","author":"Udelsman","year":"2011","journal-title":"Ann Surg."},{"key":"10.4158\/EP12166.RA_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4158\/EP10359.RA","article-title":"Surgical treatment of primary hyperparathyroidism","volume":"17","author":"Augustine","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12166.RA_bb0365","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2214\/AJR.06.0938","article-title":"Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism","volume":"188","author":"Johnson","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.4158\/EP12166.RA_bb0370","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jocd.2010.06.004","article-title":"Management of skeletal health in patients with asymptomatic primary hyperparathyroidism","volume":"12","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP12166.RA_bb0375","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0380","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP12166.RA_bb0385","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0390","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12166.RA_bb0395","series-title":"Osteoporosis in Men.","first-page":"465","article-title":"Primary hyperparathyroidism in men.","author":"Marcocci","year":"2010"},{"key":"10.4158\/EP12166.RA_bb0400","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0405","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/17446651.1.2.167","article-title":"Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism","volume":"1","author":"Locatelli","year":"2006","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0410","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/17425255.2011.562196","article-title":"Clinical utilization of cinacalcet in hypercalcemic conditions","volume":"7","author":"Messa","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.4158\/EP12166.RA_bb0415","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0425","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0430","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","article-title":"Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity","volume":"96","author":"Peacock","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0435","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12166.RA_bb0440","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical Practice: Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Eng J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/C75KM72624468278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:55:15Z","timestamp":1761515715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20429283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1530891X20429283"],"URL":"https:\/\/doi.org\/10.4158\/ep12166.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12166.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}